Caribou Biosciences, Inc. (CRBU)
1.62
+0.07
(+4.52%)
USD |
NASDAQ |
Feb 18, 16:00
1.62
0.00 (0.00%)
After-Hours: 16:02
Caribou Biosciences Market Cap : 151.42M for Feb. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 645.37M |
| GT Biopharma, Inc. | 12.79M |
| Aclaris Therapeutics, Inc. | 342.37M |
| Nurix Therapeutics, Inc. | 1.593B |
| Lyell Immunopharma, Inc. | 364.21M |
Market Cap Related Metrics
| PS Ratio | 16.13 |
| PEG Ratio | -0.3504 |
| Price to Book Value | 1.068 |
| Price | 1.62 |
| Earnings Yield | -104.8% |
| PEGY Ratio | -0.3504 |